Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b. Mult Scler. 2019 05; 25(6):837-847.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Adult
Disease Progression
Female
Follow-Up Studies
Humans
Interferon beta-1b
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting
Prognosis
Randomized Controlled Trials as Topic
Reproducibility of Results
Severity of Illness Index
authors with profiles
Anthony T. Reder